SPRIM Global Investments
Singapore, Central Singaporesprim.net
Overview
SPRIM Global Investments is a privately held investment firm specializing in clinical-stage life sciences and pharma services. SGI's innovative investment model provides agile and high-impact funding to high-potential biotech companies worldwide, supporting the advancement of clinical trials and accelerating the development of life-changing treatments. SPRIM Global Investments invests in companies that provide R&D capabilities to bring life science innovations to patients around the world.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NinaMED | May 2026 | Seed | Lead |
| Priothera | Feb 2026 | Series B | Co-investor |
| ErVimmune | Jan 2026 | Series A | Co-investor |
| KAHR Medical | Jan 2026 | VC Round | Co-investor |
| KAHR Medical | Oct 2025 | Series B | Co-investor |
Key People
Ivan Jarry
Partner, Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
